126 related articles for article (PubMed ID: 37567694)
1. Extending the enzymatic toolbox for heparosan polymerization, depolymerization, and detection.
Sulewska M; Berger M; Damerow M; Schwarzer D; Buettner FFR; Bethe A; Taft MH; Bakker H; Mühlenhoff M; Gerardy-Schahn R; Priem B; Fiebig T
Carbohydr Polym; 2023 Nov; 319():121182. PubMed ID: 37567694
[TBL] [Abstract][Full Text] [Related]
2. Glucuronyltransferase activity of KfiC from Escherichia coli strain K5 requires association of KfiA: KfiC and KfiA are essential enzymes for production of K5 polysaccharide, N-acetylheparosan.
Sugiura N; Baba Y; Kawaguchi Y; Iwatani T; Suzuki K; Kusakabe T; Yamagishi K; Kimata K; Kakuta Y; Watanabe H
J Biol Chem; 2010 Jan; 285(3):1597-606. PubMed ID: 19915003
[TBL] [Abstract][Full Text] [Related]
3. Production and characterization of low molecular weight heparosan in Bacillus megaterium using Escherichia coli K5 glycosyltransferases.
Nehru G; Tadi SRR; Limaye AM; Sivaprakasam S
Int J Biol Macromol; 2020 Oct; 160():69-76. PubMed ID: 32445821
[TBL] [Abstract][Full Text] [Related]
4. Metabolic engineering of Escherichia coli BL21 for biosynthesis of heparosan, a bioengineered heparin precursor.
Zhang C; Liu L; Teng L; Chen J; Liu J; Li J; Du G; Chen J
Metab Eng; 2012 Sep; 14(5):521-7. PubMed ID: 22781283
[TBL] [Abstract][Full Text] [Related]
5. Chaperone-assisted expression of KfiC glucuronyltransferase from Escherichia coli K5 leads to heparosan production in Escherichia coli BL21 in absence of the stabilisator KfiB.
Leroux M; Priem B
Appl Microbiol Biotechnol; 2016 Dec; 100(24):10355-10361. PubMed ID: 27484583
[TBL] [Abstract][Full Text] [Related]
6. Identification and molecular cloning of a heparosan synthase from Pasteurella multocida type D.
DeAngelis PL; White CL
J Biol Chem; 2002 Mar; 277(9):7209-13. PubMed ID: 11756462
[TBL] [Abstract][Full Text] [Related]
7. Application of Dual Promoter Expression System for the Enhanced Heparosan Production in Bacillus megaterium.
Nehru G; Tadi SRR; Sivaprakasam S
Appl Biochem Biotechnol; 2021 Aug; 193(8):2389-2402. PubMed ID: 33686628
[TBL] [Abstract][Full Text] [Related]
8. Donor substrate promiscuity of the N-acetylglucosaminyltransferase activities of Pasteurella multocida heparosan synthase 2 (PmHS2) and Escherichia coli K5 KfiA.
Li Y; Yu H; Thon V; Chen Y; Muthana MM; Qu J; Hie L; Chen X
Appl Microbiol Biotechnol; 2014 Feb; 98(3):1127-34. PubMed ID: 23661084
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of heparosan with heparin lyase III and spectrophotometry.
Huang H; Zhao Y; Lv S; Zhong W; Zhang F; Linhardt RJ
Anal Biochem; 2014 Feb; 447():46-8. PubMed ID: 24184357
[TBL] [Abstract][Full Text] [Related]
10. Identification that KfiA, a protein essential for the biosynthesis of the Escherichia coli K5 capsular polysaccharide, is an alpha -UDP-GlcNAc glycosyltransferase. The formation of a membrane-associated K5 biosynthetic complex requires KfiA, KfiB, and KfiC.
Hodson N; Griffiths G; Cook N; Pourhossein M; Gottfridson E; Lind T; Lidholt K; Roberts IS
J Biol Chem; 2000 Sep; 275(35):27311-5. PubMed ID: 10859322
[TBL] [Abstract][Full Text] [Related]
11. Heparosan Chain Characterization: Sequential Depolymerization of E. Coli K5 Heparosan by a Bacterial Eliminase Heparin Lyase III and a Bacterial Hydrolase Heparanase Bp to Prepare Defined Oligomers.
Datta P; Yan L; Awofiranye A; Dordick JS; Linhardt RJ
Biotechnol J; 2021 Mar; 16(3):e2000336. PubMed ID: 33006278
[TBL] [Abstract][Full Text] [Related]
12. Effect of eliminase gene (elmA) deletion on heparosan production and shedding in Escherichia coli K5.
Hickey AM; Bhaskar U; Linhardt RJ; Dordick JS
J Biotechnol; 2013 Jun; 165(3-4):175-7. PubMed ID: 23583654
[TBL] [Abstract][Full Text] [Related]
13. Recombinant Escherichia coli K5 strain with the deletion of waaR gene decreases the molecular weight of the heparosan capsular polysaccharide.
Huang H; Liu X; Lv S; Zhong W; Zhang F; Linhardt RJ
Appl Microbiol Biotechnol; 2016 Sep; 100(18):7877-85. PubMed ID: 27079575
[TBL] [Abstract][Full Text] [Related]
14. Preparation and application of a 'clickable' acceptor for enzymatic synthesis of heparin oligosaccharides.
Cai C; Edgar K; Liu J; Linhardt RJ
Carbohydr Res; 2013 May; 372():30-4. PubMed ID: 23524108
[TBL] [Abstract][Full Text] [Related]
15. Production of intracellular heparosan and derived oligosaccharides by lyase expression in metabolically engineered E. coli K-12.
Barreteau H; Richard E; Drouillard S; Samain E; Priem B
Carbohydr Res; 2012 Oct; 360():19-24. PubMed ID: 22975275
[TBL] [Abstract][Full Text] [Related]
16. Metabolic engineering of non-pathogenic Escherichia coli strains for the controlled production of low molecular weight heparosan and size-specific heparosan oligosaccharides.
Roy A; Miyai Y; Rossi A; Paraswar K; Desai UR; Saijoh Y; Kuberan B
Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129765. PubMed ID: 33069832
[TBL] [Abstract][Full Text] [Related]
17. Controlled Photochemical Depolymerization of K5 Heparosan, a Bioengineered Heparin Precursor.
Higashi K; Ly M; Wang Z; Masuko S; Bhaskar U; Sterner E; Zhang F; Toida T; Dordick JS; Linhardt RJ
Carbohydr Polym; 2011 Aug; 86(3):1365-1370. PubMed ID: 21841848
[TBL] [Abstract][Full Text] [Related]
18. E. coli K5 fermentation and the preparation of heparosan, a bioengineered heparin precursor.
Wang Z; Ly M; Zhang F; Zhong W; Suen A; Hickey AM; Dordick JS; Linhardt RJ
Biotechnol Bioeng; 2010 Dec; 107(6):964-73. PubMed ID: 20717972
[TBL] [Abstract][Full Text] [Related]
19. Metabolic engineering of Bacillus megaterium for heparosan biosynthesis using Pasteurella multocida heparosan synthase, PmHS2.
Williams A; Gedeon KS; Vaidyanathan D; Yu Y; Collins CH; Dordick JS; Linhardt RJ; Koffas MAG
Microb Cell Fact; 2019 Aug; 18(1):132. PubMed ID: 31405374
[TBL] [Abstract][Full Text] [Related]
20. Determination of the substrate specificities of N-acetyl-d-glucosaminyltransferase.
Chen M; Bridges A; Liu J
Biochemistry; 2006 Oct; 45(40):12358-65. PubMed ID: 17014088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
